Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$36.90 +1.31 (+3.68%)
Closing price 04:00 PM Eastern
Extended Trading
$36.87 -0.03 (-0.08%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PNTG vs. SHC, BLLN, OPCH, PRVA, and CON

Should you buy The Pennant Group stock or one of its competitors? MarketBeat compares The Pennant Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with The Pennant Group include Sotera Health (SHC), Billiontoone (BLLN), Option Care Health (OPCH), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

How does The Pennant Group compare to Sotera Health?

The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Comparatively, 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

The Pennant Group has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market.

In the previous week, The Pennant Group had 9 more articles in the media than Sotera Health. MarketBeat recorded 15 mentions for The Pennant Group and 6 mentions for Sotera Health. The Pennant Group's average media sentiment score of 0.83 beat Sotera Health's score of 0.79 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
5 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sotera Health
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

The Pennant Group currently has a consensus target price of $39.00, indicating a potential upside of 5.69%. Sotera Health has a consensus target price of $20.33, indicating a potential upside of 31.27%. Given Sotera Health's higher possible upside, analysts plainly believe Sotera Health is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

Sotera Health has a net margin of 9.91% compared to The Pennant Group's net margin of 2.96%. Sotera Health's return on equity of 39.73% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.96% 10.07% 4.23%
Sotera Health 9.91%39.73%7.05%

Sotera Health has higher revenue and earnings than The Pennant Group. Sotera Health is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.02B1.25$29.58M$0.8543.41
Sotera Health$1.16B3.80$77.94M$0.4137.78

Summary

Sotera Health beats The Pennant Group on 11 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to Billiontoone?

The Pennant Group (NASDAQ:PNTG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

The Pennant Group has a net margin of 2.96% compared to Billiontoone's net margin of 0.00%. The Pennant Group's return on equity of 10.07% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.96% 10.07% 4.23%
Billiontoone N/A N/A N/A

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.02B1.25$29.58M$0.8543.41
Billiontoone$354.54M11.40$7.45M$0.55159.89

In the previous week, The Pennant Group had 9 more articles in the media than Billiontoone. MarketBeat recorded 15 mentions for The Pennant Group and 6 mentions for Billiontoone. The Pennant Group's average media sentiment score of 0.83 beat Billiontoone's score of 0.55 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
5 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.9% of The Pennant Group shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

The Pennant Group currently has a consensus target price of $39.00, indicating a potential upside of 5.69%. Billiontoone has a consensus target price of $125.29, indicating a potential upside of 42.47%. Given Billiontoone's higher possible upside, analysts plainly believe Billiontoone is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

The Pennant Group beats Billiontoone on 11 of the 14 factors compared between the two stocks.

How does The Pennant Group compare to Option Care Health?

The Pennant Group (NASDAQ:PNTG) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Option Care Health has a net margin of 3.64% compared to The Pennant Group's net margin of 2.96%. Option Care Health's return on equity of 18.17% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.96% 10.07% 4.23%
Option Care Health 3.64%18.17%7.16%

Option Care Health has higher revenue and earnings than The Pennant Group. Option Care Health is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.02B1.25$29.58M$0.8543.41
Option Care Health$5.67B0.55$207.59M$1.2915.47

The Pennant Group has a beta of 1.28, meaning that its share price is 28% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

In the previous week, The Pennant Group had 1 more articles in the media than Option Care Health. MarketBeat recorded 15 mentions for The Pennant Group and 14 mentions for Option Care Health. The Pennant Group's average media sentiment score of 0.83 beat Option Care Health's score of 0.81 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
5 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 98.1% of Option Care Health shares are held by institutional investors. 6.9% of The Pennant Group shares are held by company insiders. Comparatively, 1.7% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

The Pennant Group currently has a consensus target price of $39.00, indicating a potential upside of 5.69%. Option Care Health has a consensus target price of $31.25, indicating a potential upside of 56.64%. Given Option Care Health's higher probable upside, analysts plainly believe Option Care Health is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75
Option Care Health
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.69

Summary

Option Care Health beats The Pennant Group on 10 of the 17 factors compared between the two stocks.

How does The Pennant Group compare to Privia Health Group?

The Pennant Group (NASDAQ:PNTG) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

The Pennant Group has a net margin of 2.96% compared to Privia Health Group's net margin of 0.97%. The Pennant Group's return on equity of 10.07% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.96% 10.07% 4.23%
Privia Health Group 0.97%2.81%1.61%

The Pennant Group has higher earnings, but lower revenue than Privia Health Group. The Pennant Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.02B1.25$29.58M$0.8543.41
Privia Health Group$2.12B1.38$22.92M$0.16145.25

The Pennant Group has a beta of 1.28, meaning that its share price is 28% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

In the previous week, Privia Health Group had 6 more articles in the media than The Pennant Group. MarketBeat recorded 21 mentions for Privia Health Group and 15 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.83 beat Privia Health Group's score of 0.41 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
5 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Privia Health Group
8 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 6.9% of The Pennant Group shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

The Pennant Group currently has a consensus target price of $39.00, indicating a potential upside of 5.69%. Privia Health Group has a consensus target price of $31.23, indicating a potential upside of 34.38%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts plainly believe Privia Health Group is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75
Privia Health Group
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79

Summary

The Pennant Group and Privia Health Group tied by winning 8 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to Concentra Group Holdings Parent?

Concentra Group Holdings Parent (NYSE:CON) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Concentra Group Holdings Parent currently has a consensus price target of $30.25, indicating a potential upside of 15.80%. The Pennant Group has a consensus price target of $39.00, indicating a potential upside of 5.69%. Given Concentra Group Holdings Parent's stronger consensus rating and higher probable upside, equities research analysts clearly believe Concentra Group Holdings Parent is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

Concentra Group Holdings Parent has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market.

Concentra Group Holdings Parent has a net margin of 7.97% compared to The Pennant Group's net margin of 2.96%. Concentra Group Holdings Parent's return on equity of 47.14% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Concentra Group Holdings Parent7.97% 47.14% 6.48%
The Pennant Group 2.96%10.07%4.23%

Concentra Group Holdings Parent has higher revenue and earnings than The Pennant Group. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concentra Group Holdings Parent$2.23B1.50$166.41M$1.3918.79
The Pennant Group$1.02B1.25$29.58M$0.8543.41

In the previous week, Concentra Group Holdings Parent had 7 more articles in the media than The Pennant Group. MarketBeat recorded 22 mentions for Concentra Group Holdings Parent and 15 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.83 beat Concentra Group Holdings Parent's score of 0.59 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concentra Group Holdings Parent
6 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Pennant Group
5 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.9% of The Pennant Group shares are owned by institutional investors. 8.1% of Concentra Group Holdings Parent shares are owned by company insiders. Comparatively, 6.9% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Concentra Group Holdings Parent beats The Pennant Group on 11 of the 16 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.28B$5.57B$6.29B$12.46B
Dividend YieldN/A1.56%2.79%5.30%
P/E Ratio43.4134.6920.8925.59
Price / Sales1.2522.68522.1762.83
Price / Cash27.6416.4642.9455.34
Price / Book3.293.159.866.70
Net Income$29.58M$218.81M$3.55B$333.77M
7 Day Performance3.27%-0.05%-0.32%0.45%
1 Month Performance20.39%3.72%1.33%4.06%
1 Year Performance25.90%20.19%41.10%36.24%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
3.4878 of 5 stars
$36.90
+3.7%
$39.00
+5.7%
+22.0%$1.28B$1.02B43.419,700
SHC
Sotera Health
3.9243 of 5 stars
$15.80
+3.1%
$20.33
+28.7%
+16.9%$4.37B$1.16B38.543,000
BLLN
Billiontoone
4.035 of 5 stars
$81.40
+1.9%
$126.71
+55.7%
N/A$3.67B$305.11M387.62620
OPCH
Option Care Health
4.9386 of 5 stars
$20.45
-4.0%
$31.25
+52.8%
-37.3%$3.34B$5.65B15.858,266
PRVA
Privia Health Group
4.0365 of 5 stars
$23.99
-1.2%
$31.31
+30.5%
-6.9%$3.05B$2.12B141.121,226

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners